Insider Selling: National Research Co. (NASDAQ:NRC) CFO Sells $328,031.04 in Stock

National Research Co. (NASDAQ:NRC – Get Rating) CFO Kevin R. Karas sold 7,156 shares of the business’s stock in a transaction on Friday, February 24th. The stock was sold at an average price of $45.84, for a total value of $328,031.04. Following the completion of the transaction, the chief financial officer now directly owns 10,140 shares in the company, valued at approximately $464,817.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

National Research Stock Up 1.5 %

NRC stock opened at $45.40 on Friday. The stock’s fifty day simple moving average is $43.30 and its two-hundred day simple moving average is $39.86. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.28. National Research Co. has a 1-year low of $30.93 and a 1-year high of $47.60. The stock has a market cap of $1.12 billion, a P/E ratio of 35.75 and a beta of 0.50.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 14th. Stockholders of record on Friday, March 31st will be given a dividend of $0.12 per share. The ex-dividend date is Thursday, March 30th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.06%. National Research’s dividend payout ratio is presently 37.80%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Morgan Stanley lifted its position in shares of National Research by 4,323.8% during the 4th quarter. Morgan Stanley now owns 974,253 shares of the company’s stock valued at $36,340,000 after buying an additional 952,230 shares during the last quarter. BlackRock Inc. lifted its position in shares of National Research by 0.3% during the 1st quarter. BlackRock Inc. now owns 921,600 shares of the company’s stock valued at $36,541,000 after buying an additional 3,053 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of National Research by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 851,253 shares of the company’s stock valued at $33,879,000 after buying an additional 6,494 shares during the last quarter. State Street Corp lifted its position in shares of National Research by 6.3% during the 1st quarter. State Street Corp now owns 308,746 shares of the company’s stock valued at $12,315,000 after buying an additional 18,237 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of National Research by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 304,145 shares of the company’s stock valued at $11,344,000 after buying an additional 6,945 shares during the last quarter. Hedge funds and other institutional investors own 68.04% of the company’s stock.

Wall Street Analyst Weigh In

Separately, TheStreet raised National Research from a “c+” rating to a “b-” rating in a research report on Tuesday, January 31st.

About National Research

(Get Rating)

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations.